Keros CMO Simon Cooper resigns effective March 12, 2024

Keros Therapeutics, Inc.

Simon Cooper, M.B.B.S., voluntarily resigned as CMO effective March 12, 2024, to pursue other opportunities.
Resignation is not due to any disagreement with the company.
Company has commenced a search for a new Chief Medical Officer.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Simon Cooper

Chief Medical Officer

KROS · Keros Therapeutics, Inc.

Effective: 2024-03-12
Filed: March 5, 2024, 6:59 PM ET

On February 29, 2024, Simon Cooper, M.B.B.S., resigned from his position as Chief Medical Officer of Keros Therapeutics, Inc. (the “Company”), effective March 12, 2024, to pursue other opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Simon Cooper resigned as Chief Medical Officer at Keros Therapeutics, Inc..

Action: resigned
Role: Chief Medical Officer

Exact text from the filing

On February 29, 2024, Simon Cooper, M.B.B.S., resigned from his position as Chief Medical Officer of Keros Therapeutics, Inc. (the “Company”), effective March 12, 2024, to pursue other opportunities.

View on SEC.gov

Keros Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001664710-24-000026

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.